[
  {
    "ts": "2025-11-23T05:55:12+00:00",
    "headline": "Abbott’s (ABT) Exact Sciences Deal is “Very, Very Important,” Says Jim Cramer",
    "summary": "We recently published 10 Stocks Jim Cramer Talked About. Abbott Laboratories (NYSE:ABT) is one of the stocks Jim Cramer discussed. This show marked more than a month after Cramer discussed pharmaceuticals and diagnostics devices firm Abbott Laboratories (NYSE:ABT). However, the delay doesn’t mean he’s changed his sentiment about the firm. Cramer often calls Abbott Laboratories […]",
    "url": "https://finance.yahoo.com/news/abbott-abt-exact-sciences-deal-055512150.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "ac9fc8b7-3156-3261-b005-0c44547fe8c3",
      "content": {
        "id": "ac9fc8b7-3156-3261-b005-0c44547fe8c3",
        "contentType": "STORY",
        "title": "Abbott’s (ABT) Exact Sciences Deal is “Very, Very Important,” Says Jim Cramer",
        "description": "",
        "summary": "We recently published 10 Stocks Jim Cramer Talked About. Abbott Laboratories (NYSE:ABT) is one of the stocks Jim Cramer discussed. This show marked more than a month after Cramer discussed pharmaceuticals and diagnostics devices firm Abbott Laboratories (NYSE:ABT). However, the delay doesn’t mean he’s changed his sentiment about the firm. Cramer often calls Abbott Laboratories […]",
        "pubDate": "2025-11-23T05:55:12Z",
        "displayTime": "2025-11-23T05:55:12Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/6fb8d32c361720907cdeb11568fb29d0",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Abbott's (ABT) Exact Sciences Deal is \"Very, Very Important,\" Says Jim Cramer",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.hSr7G9mXRyAs1EXrbdaEg--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/6fb8d32c361720907cdeb11568fb29d0.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/G4I7kCmhXlRU1ZsYOmrcoA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/6fb8d32c361720907cdeb11568fb29d0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbott-abt-exact-sciences-deal-055512150.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbott-abt-exact-sciences-deal-055512150.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            },
            {
              "symbol": "EXAS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]